BiasDB: A Comprehensive Database for Biased GPCR Ligands
Omieczynski, C.; Nguyen, T. N.; Sribar, D.; Deng, L.; Stepanov, D.; Schaller, D.; Wolber, G.; Bermudez, M.
Show abstract
G protein-coupled receptors transmit signals across membranes via interaction with intracellular binding partners. While there is an imprinted signaling profile for each receptor, biased ligands are able to shift intracellular pathways resulting in different recruitment profiles. We present the first comprehensive database of all literature-known biased ligands as a resource for medicinal chemistry and pharmacology. In addition to careful manual curation, we provide an analysis of the data. BiasDB is available at https://biasdb.drug-design.de/.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2 94%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 92%
- Towards high-resolution modeling of small molecule-ion channel interactions 91%
Similar papers in this journal
- A Simple Way to Incorporate Target Structural Information in Molecular Generative Models 94%
- The use of a graph database is a complementary approach to a classical similarity search for identifying commercially available fragment merges 94%
- Understanding and predicting ligand efficacy in the mu-opioid receptor through quantitative dynamical analysis of complex structures 94%
Similar papers in this journal
- Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents 96%
- A hybrid in silico approach reveals novel inhibitors of multiple SARS-CoV-2 variants 94%
- A blueprint for high affinity SARS-CoV-2 Mpro inhibitors from activity-based compound library screening guided by analysis of protein dynamics 94%
Similar papers in this journal
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 94%
- HTRF-based identification of small molecules targeting SARS-CoV-2 E protein interaction with ZO-1 PDZ2 93%
- COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.